Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;22(12):2120-2127.
doi: 10.3201/eid2212.161136.

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015

Johan van Griensven et al. Emerg Infect Dis. 2016 Dec.

Abstract

By using data from a 2015 clinical trial on Ebola convalescent-phase plasma in Guinea, we assessed the prevalence of electrolyte and metabolic abnormalities at admission and their predictive value to stratify patients into risk groups. Patients underwent testing with a point-of-care device. We used logistic regression to construct a prognostic model and summarized the predictive value with the area under the receiver operating curve. Abnormalities were common among patients, particularly hypokalemia, hypocalcemia, hyponatremia, raised creatinine, high anion gap, and anemia. Besides age and PCR cycle threshold value, renal dysfunction, low calcium levels, and low hemoglobin levels were independently associated with increased risk for death. A prognostic model using all 5 factors was highly discriminatory (area under the receiver operating curve 0.95; 95% CI 0.90-0.99) and enabled the definition of risk criteria to guide targeted care. Most patients had a very low (<5%) or very high (>80%) risk for death.

Keywords: EVD; Ebola; Guinea; clinical trial; death; electrolyte; infectious disease; metabolic; model; mortality; point of care; prediction; risk; viruses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram displaying the distribution of the risk for death for Ebola patients recruited for the Ebola-Tx trial, Conakry, Guinea, 2015, according to a 5-variable point-of-care (POC+) prognostic prediction model. POC+ model includes 3 POC measurements (blood creatinine, calcium, and hemoglobin) plus the cycle threshold value of the diagnostic Ebola PCR result and the age of the patient. ETU, Ebola treatment unit.
Figure 2
Figure 2
Receiving operating curve summarizing the performance of 3-variable point-of-care (POC) and 5-variable POC+ prognostic prediction models for Ebola patients recruited for the Ebola-Tx trial, Conakry, Guinea, 2015. POC model includes blood creatinine, hemoglobin, and calcium levels. POC+ model includes the same 3 POC measurements plus the cycle threshold value of the diagnostic Ebola PCR result and the age of the patient. AUROC, area under the receiver operating curve; POC, point-of-care.

References

    1. World Health Organization. Ebola situation report—30 March 2016. [cited 2016 Jun 1]. http://apps.who.int/ebola/current-situation/ebola-situation-report-30-ma...
    1. van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, et al.; Ebola-Tx Consortium. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med. 2016;374:33–42.10.1056/NEJMoa1511812 - DOI - PMC - PubMed
    1. Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, et al.; RAPIDE-TKM trial team. Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial. PLoS Med. 2016;13:e1001997.10.1371/journal.pmed.1001997 - DOI - PMC - PubMed
    1. Sissoko D, Laouenan C, Folkesson E, M’Lebing AB, Beavogui AH, Baize S, et al.; JIKI Study Group. Experimental treatment with favipiravir for Ebola Virus Disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967.10.1371/journal.pmed.1001967 - DOI - PMC - PubMed
    1. Fletcher TE, Fowler RA, Beeching NJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med. 2014;40:1936–9.10.1007/s00134-014-3515-1 - DOI - PubMed

MeSH terms